FDB Adds Boxed Warning Content to Help Ensure Patient Safety with High Risk Medications
August 07, 2014
Posted August 7, 2014 - FDB adds boxed warning content to the FDB High Risk Medication Module to ensure patient safety and regulatory compliance with high risk medications within the clinical workflow.
Innovative Integrated Medicine’s Management Solution being presented at the June 2014 Commissioning Show
June 23, 2014
Posted 23 June 2014 - Lincolnshire East Clinical Commissioning Group (LECCG) will be presenting their experiences of the OptimiseRx electronic medicines management clinical decision support pilot which concluded in early 2014.
FDB to Present Poster on the Quality and Consistency of Grapefruit Juice Drug Interaction Information at Patient Safety Conference
May 14, 2014
Posted May 13, 2014 - FDB research on the quality and consistency of grapefruit juice drug interaction information, presented at NPSF Conference, reveals numerous inconsistencies in manufacturer-authored drug labeling.
FDB to Present Expert Panel Drug Dosing Recommendations at 2014 Pediatric Pharmacy Conference
April 30, 2014
Posted April 30, 2014 - FDB to Present Expert Panel Pediatric Drug Dosing Recommendations at 2014 Pediatric Pharmacy Conference
FDB to Present Drug Pricing Analysis Poster Comparing AWP and WAC to AAC Benchmarks
March 31, 2014
Posted March 31, 2014 - FDB Drug Pricing Analysis Poster Comparing AWP and WAC to AAC Benchmarks finds acquisition cost-based benchmarks a more reliable measure for drug cost effectiveness studies.
FDB MedsTracker® Achieves 2014 Edition Modular EHR Health IT Certification from ICSA Labs
March 20, 2014
March 20, 2014 - FDB MedsTracker® achieves 2014 Edition Modular EHR Health IT Certification from ICSA Labs for both inpatient and ambulatory settings. This certification designates that FDB MedsTracker is capable of supporting healthcare providers with Stage 1 and Stage 2 Meaningful Use measures required to qualify for funding under the American Recovery and Reinvestment Act (ARRA).